Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mulder

Showing results (441-450 of 450) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 450 results.
Frontiers in Cardiovascular Medicine|October 24, 2022
Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID CohortTom W van de Berg, Mark M G Mulder, Teba Alnima, et al.
Thrombosis Research|October 22, 2020
The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparisonRenée A G Brüggemann, Bart Spaetgens, Hester A Gietema, et al.
Clinical and Translational Radiation Oncology|April 21, 2026
Outcomes after (chemo)radiotherapy for anal cancer - A nationwide cohort studyC L Deijen, M Berbée, E D Geijsen, et al.
Thrombosis Research|June 1, 2026
Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohortJoep Schellens, Magdolna Nagy, Anne-Marije Hulshof, et al.
Journal of Intensive Care|December 19, 2023
Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohortMark M G Mulder, Joep Schellens, Jan-Willem E M Sels, et al.
Thrombosis Journal|June 1, 2021
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohortMark M G Mulder, LIoyd Brandts, Renée A G Brüggemann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Selective tumor antigen vaccine delivery to human CD169<sup>+</sup> antigen-presenting cells using ganglioside-liposomesAlsya J Affandi, Joanna Grabowska, Katarzyna Olesek, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|November 25, 2020
Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMOAlexander S Streng, Thijs S R Delnoij, Mark M G Mulder, et al.
Scientific Reports|August 25, 2022
Pulmonary pathophysiology development of COVID-19 assessed by serial Electrical Impedance Tomography in the MaastrICCht cohortSerge J H Heines, Bas C T van Bussel, Melanie J Acampo-de Jong, et al.
BMJ Open|September 30, 2020
Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht)Jeanette Tas, Rob J J van Gassel, Serge J H Heines, et al.
Pageof 45

Showing results (441-450 of 450) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 450 results.
Frontiers in Cardiovascular Medicine|October 24, 2022
Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID CohortTom W van de Berg, Mark M G Mulder, Teba Alnima, et al.
Thrombosis Research|October 22, 2020
The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparisonRenée A G Brüggemann, Bart Spaetgens, Hester A Gietema, et al.
Clinical and Translational Radiation Oncology|April 21, 2026
Outcomes after (chemo)radiotherapy for anal cancer - A nationwide cohort studyC L Deijen, M Berbée, E D Geijsen, et al.
Thrombosis Research|June 1, 2026
Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohortJoep Schellens, Magdolna Nagy, Anne-Marije Hulshof, et al.
Journal of Intensive Care|December 19, 2023
Higher levels of circulating desphospho-uncarboxylated matrix Gla protein over time are associated with worse survival: the prospective Maastricht Intensive Care COVID cohortMark M G Mulder, Joep Schellens, Jan-Willem E M Sels, et al.
Thrombosis Journal|June 1, 2021
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohortMark M G Mulder, LIoyd Brandts, Renée A G Brüggemann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2020
Selective tumor antigen vaccine delivery to human CD169<sup>+</sup> antigen-presenting cells using ganglioside-liposomesAlsya J Affandi, Joanna Grabowska, Katarzyna Olesek, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|November 25, 2020
Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMOAlexander S Streng, Thijs S R Delnoij, Mark M G Mulder, et al.
Scientific Reports|August 25, 2022
Pulmonary pathophysiology development of COVID-19 assessed by serial Electrical Impedance Tomography in the MaastrICCht cohortSerge J H Heines, Bas C T van Bussel, Melanie J Acampo-de Jong, et al.
BMJ Open|September 30, 2020
Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht)Jeanette Tas, Rob J J van Gassel, Serge J H Heines, et al.
Pageof 45